Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Undecane SCHEMBL20589952 | 0.96 | GPR84 (0.55) | CA2MAPK1GPR84FFAR1ACE2 | |
| SCHEMBL5907622 | 0.93 | GPR84 (0.57) | GPR84FFAR1ACE2SLC1A2SLC1A1 | |
| SCHEMBL8982238 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL22552773 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL5171539 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL9431401 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL9487795 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL4269015 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL5907640 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL9485889 | 0.91 | GPR84 (0.61) | GPR84FFAR1ACE2MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12532886-B2 | Method of killing microbes using C3-C5 n-alkyl-gamma-butyrolactams and antimicrobial compositions containing same | VIROX TECHNOLOGIES INC. (CA) | 2026-01-27 | — | — | US | claimed |
| US-12446578-B2 | Antimicrobial compositions containing peroxyphthalic acid and/or salt thereof | VIROX TECHNOLOGIES INC. (CA) | 2025-10-21 | — | — | US | claimed |
| US-12052990-B2 | C3-C5 n-alkyl-gamma-butyrolactam containing antimicrobial compositions and methods of using same | VIROX TECHNOLOGIES INC. (CA) | 2024-08-06 | — | — | US | claimed |
| US-20230374269-A1 | WATER-SOLUBLE COMPOSITION COMPRISING LYSOPHOSPHATIDYLETHANOLAMINE AND HAVING IMPROVED STABILITY, AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2023-11-23 | — | — | US | claimed |
| WO-2023075664-A1 | A DISINFECTANT FILM-FORMING COMPOSITION AND A DRY DISINFECTANT FILM FORMED ON A SURFACE FROM THE FILM FORMING COMPOSITION | Rise Research Institutes of Sweden AB (SE) | 2023-05-04 | — | — | WO | claimed |
| US-20220400671-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING PEROXYPHTHALIC ACID AND/OR SALT THEREOF | VIROX TECHNOLOGIES INC. (CA) | 2022-12-22 | — | — | US | claimed |
| EP-4102971-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING PEROXYPHTHALIC ACID AND/OR SALT THEREOF | Virox Technologies Inc. (CA) | 2022-12-21 | — | — | EP | claimed |
| EP-4098732-A1 | A NOVEL MINIMUM BOILING AZEOTROPE OF N-BUTYL-3-HYDROXYBUTYRATE AND N-UNDECANE AND APPLICATION OF THE AZEOTROPE TO SOLVENT CLEANING | Eastman Chemical Company (US) | 2022-12-07 | — | — | EP | claimed |
| EP-3638764-B1 | A NOVEL MINIMUM BOILING AZEOTROPE OF N-BUTYL-3-HYDROXYBUTYRATE AND N-UNDECANE AND APPLICATION OF THE AZEOTROPE TO SOLVENT CLEANING | EASTMAN CHEM CO (US) | 2022-05-11 | — | — | EP | claimed |
| US-20210386066-A1 | C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM CONTAINING ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING SAME | VIROX TECHNOLOGIES INC. (CA) | 2021-12-16 | — | — | US | claimed |
| WO-2021161148-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING PEROXYPHTHALIC ACID AND/OR SALT THEREOF | VIROX TECHNOLOGIES INC. (CA) | 2021-08-19 | — | — | WO | claimed |
| CN-110023470-B | Cleaning composition and test method for intake valve deposits | 胜牌许可和知识产权有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-110753747-B | Novel minimum boiling azeotropes of n-butyl 3-hydroxybutyrate and n-undecane and their use in solvent cleaning | 伊士曼化工公司 | 2021-06-25 | — | — | CN | claimed |
| EP-3638764-A1 | A NOVEL MINIMUM BOILING AZEOTROPE OF N-BUTYL-3-HYDROXYBUTYRATE AND N-UNDECANE AND APPLICATION OF THE AZEOTROPE TO SOLVENT CLEANING | Eastman Chemical Company (US) | 2020-04-22 | — | — | EP | claimed |
| CN-110753747-A | Novel minimum boiling azeotropes of n-butyl 3-hydroxybutyrate and n-undecane and their use in solvent cleaning | 伊士曼化工公司 | 2020-02-04 | — | — | CN | claimed |
| US-10233410-B2 | Minimum boiling azeotrope of n-butyl-3-hydroxybutyrate and n-undecane and application of the azeotrope to solvent cleaning | EASTMAN CHEMICAL COMPANY (US) | 2019-03-19 | — | — | US | claimed |
| US-20180362894-A1 | NOVEL MINIMUM BOILING AZEOTROPE OF N-BUTYL-3-HYDROXYBUTYRATE AND N-UNDECANE AND APPLICATION OF THE AZEOTROPE TO SOLVENT CLEANING | EASTMAN CHEMICAL COMPANY (US) | 2018-12-20 | — | — | US | claimed |
| WO-2018231689-A1 | A NOVEL MINIMUM BOILING AZEOTROPE OF N-BUTYL-3-HYDROXYBUTYRATE AND N-UNDECANE AND APPLICATION OF THE AZEOTROPE TO SOLVENT CLEANING | EASTMAN CHEMICAL COMPANY (US) | 2018-12-20 | — | — | WO | claimed |
| CN-101613314-B | Preparation method of antihypertensive drug felodipine | HEFEI LIFEON PHARMACEUTIAL CO | 2011-11-09 | — | — | CN | claimed |
| CN-101613314-A | The preparation method of antihypertensive drug felodipine | HEFEI LIFANG MEDICATION CO LTD | 2009-12-30 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12532886-B2 | Method of killing microbes using C3-C5 n-alkyl-gamma-butyrolactams and antimicrobial compositions containing same | C5, C9, C1S | CA2 2188/4885MAPK1 3095/4885GPR84 2129/4885 |
| US-12052990-B2 | C3-C5 n-alkyl-gamma-butyrolactam containing antimicrobial compositions and methods of using same | C5, C1S, C9 | CA2 2561/4885MAPK1 3651/4885GPR84 2149/4885 |
| US-20210386066-A1 | C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM CONTAINING ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING SAME | C5, C1S, C9 | CA2 2561/4885MAPK1 3651/4885GPR84 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.